Charles River Laboratories International Balance Sheet Health
Financial Health criteria checks 4/6
Charles River Laboratories International has a total shareholder equity of $3.7B and total debt of $2.6B, which brings its debt-to-equity ratio to 71.7%. Its total assets and total liabilities are $8.2B and $4.5B respectively. Charles River Laboratories International's EBIT is $656.2M making its interest coverage ratio 5. It has cash and short-term investments of $276.8M.
Key information
71.7%
Debt to equity ratio
US$2.62b
Debt
Interest coverage ratio | 5x |
Cash | US$276.77m |
Equity | US$3.66b |
Total liabilities | US$4.54b |
Total assets | US$8.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RV6's short term assets ($1.6B) exceed its short term liabilities ($1.1B).
Long Term Liabilities: RV6's short term assets ($1.6B) do not cover its long term liabilities ($3.5B).
Debt to Equity History and Analysis
Debt Level: RV6's net debt to equity ratio (64.2%) is considered high.
Reducing Debt: RV6's debt to equity ratio has reduced from 122.3% to 71.7% over the past 5 years.
Debt Coverage: RV6's debt is well covered by operating cash flow (26.1%).
Interest Coverage: RV6's interest payments on its debt are well covered by EBIT (5x coverage).